Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kai‐Cheng Peng
Observed names:
K. Peng,
Kai-Cheng Peng
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Children's Hospital of Chongqing Medical University,
Chongqing Municipal Health Commission,
Southern Medical University,
Chongqing Medical University
show all 6
Observed institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Children's Hospital of Chongqing Medical University,
Chongqing Municipal Health Commission,
Southern Medical University,
Chongqing Medical University,
South China University of Technology
show all 7
ORCID:
0000-0002-8094-9720
Observed ORCID:
0000-0002-8094-9720
OpenAlex ID:
A5022277260
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
2023
·
Han-Min Wang
, Chan-Yuan Zhang
, et al.
·
Cell Reports Medicine
·
263
Clinical outcomes of EGFR +/ METamp + vs. EGFR +/ METamp ‐ untreated patients with advanced non‐small cell lung cancer
2022
·
Kai‐Cheng Peng
, Jun‐Wei Su
, et al.
·
Thoracic Cancer
·
20
Tumor immune microenvironment of NSCLC with EGFR exon 20 insertions may predict efficacy of first-line ICI-combined regimen
2024
·
Ke-Jun Liu
, Hong-Rui Li
, et al.
·
Lung Cancer
·
14
PDF
Clinicopathological features and resistance mechanisms in HIP1‐ALK ‐rearranged lung cancer: A multicenter study
2021
·
Jin Kang
, Qiu‐Mei Deng
, et al.
·
Genes Chromosomes and Cancer
·
14
The Global, Regional, and National Burden of Lower Respiratory Infections Caused by Streptococcus pneumoniae Between 1990 and 2021
2025
·
Jin Xiong
, Zhenxuan Kong
, et al.
·
Healthcare
·
13
PDF
MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma
2021
·
C. Zhang
, S. Zhang
, et al.
·
Journal of Thoracic Oncology
·
9
The combination of immune checkpoint inhibitor and chemotherapy may be efficacious for advanced non-small cell lung cancer with near-loop insertions of EGFR exon 20: A retrospective analysis
2025
·
Ke-Jun Liu
, Hong-Rui Li
, et al.
·
Science Progress
·
1
PDF
Low infiltration of CD8+ FOXP3+ T cells associated with favorable clinical outcomes after first-line targeted therapy in EGFR exon 21 mutated lung adenocarcinoma patients.
2022
·
Kejun Liu
, Quanquan Tan
, et al.
·
Journal of Clinical Oncology
Patient-derived organoids to predict the drug response in locally advanced or metastatic lung cancer: A real-world study.
2022
·
Chan-Yuan Zhang
, Han-Min Wang
, et al.
·
Journal of Clinical Oncology
P76.81 Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma harboring EGFR–RAD51 Fusion: A Brief Report
2021
·
H. Wang
, K. Peng
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
334
H-index:
6
I10-index:
5
Year
Topic
Type